{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:31Z","timestamp":1786988071158,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273795"],"award-info":[{"award-number":["82273795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22007020"],"award-info":[{"award-number":["22007020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejmech.2024.116325","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T12:27:56Z","timestamp":1710505676000},"page":"116325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Raloxifene-driven benzothiophene derivatives: Discovery, structural refinement, and biological evaluation as potent PPAR\u03b3 modulators based on drug repurposing"],"prefix":"10.1016","volume":"269","author":[{"given":"Qingmei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7936-9326","authenticated-orcid":false,"given":"Wei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116325_bib1","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2024.116325_bib2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00125-019-4909-y","article-title":"Type 2 diabetes: a multifaceted disease","volume":"62","author":"Pearson","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2024.116325_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11892-019-1201-y","article-title":"Type 2 diabetes mellitus, insulin resistance, and vitamin D","volume":"19","author":"Sacerdote","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.ejmech.2024.116325_bib4","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116325_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular complications of Type 2 diabetes mellitus","volume":"18","author":"Viigimaa","year":"2022","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116325_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154838","article-title":"Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes","volume":"123","author":"Yun","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.ejmech.2024.116325_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11892-021-01383-7","article-title":"The relationship between Type 2 diabetes, NAFLD, and cardiovascular risk","volume":"21","author":"Caussy","year":"2021","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.ejmech.2024.116325_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106918","article-title":"Sulforaphane: a nutraceutical against diabetes-related complications","volume":"196","author":"Mthembu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116325_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","article-title":"PPAR gamma gene-a review","volume":"9","author":"Janani","year":"2015","journal-title":"Diabetes Metabol. Syndr."},{"key":"10.1016\/j.ejmech.2024.116325_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2024.116325_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101117","article-title":"PARPs in lipid metabolism and related diseases","volume":"84","author":"Sz\u00e1nt\u00f3","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejmech.2024.116325_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1210\/en.2008-0899","article-title":"Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis","volume":"150","author":"Sarruf","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2024.116325_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.phrs.2016.02.028","article-title":"PPAR\u03b3 signaling and emerging opportunities for improved therapeutics","volume":"111","author":"Wang","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116325_bib14","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.str.2021.02.006","article-title":"Structural mechanism underlying ligand binding activation of PPAR\u03b3","volume":"29","author":"Shang","year":"2021","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2024.116325_bib15","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1248\/bpb.b21-00263","article-title":"Insights into dynamic mechanism of ligand binding to peroxisome proliferator-activated receptor \u03b3 toward potential pharmacological applications","volume":"44","author":"Miyamae","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2024.116325_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/816856","article-title":"Review of the structural and dynamic mechanisms of PPAR\u03b3 partial agonism","volume":"2015","author":"Kroker","year":"2015","journal-title":"PPAR Res."},{"key":"10.1016\/j.ejmech.2024.116325_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.str.2011.12.002","article-title":"Couple dynamics: PPAR\u03b3 and its ligand partners","volume":"20","author":"Yu","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2024.116325_bib18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41467-020-14750-x","article-title":"A molecular switch regulating transcriptional repression and activation of PPAR\u03b3","volume":"11","author":"Shang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116325_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41598-017-18274-1","article-title":"Structural basis for the enhanced anti-diabetic efficacy of lobeglitazone on PPAR\u03b3","volume":"8","author":"Jang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116325_bib20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.str.2007.07.014","article-title":"Partial agonists activate PPARgamma using a helix 12 independent mechanism","volume":"15","author":"Bruning","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2024.116325_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11892-019-1270-y","article-title":"Thiazolidinediones: the forgotten diabetes medications","volume":"19","author":"Lebovitz","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.ejmech.2024.116325_bib22","first-page":"45","article-title":"Design, synthesis and in vitro evaluation of a series thiazolidinediones analogs as PPAR modulators, Chinese","volume":"18","author":"Feng","year":"2007","journal-title":"Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116325_bib23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10822-011-9446-9","article-title":"Structural insights for the design of new PPARgamma partial agonists with high binding affinity and low transactivation activity","volume":"25","author":"Guasch","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2024.116325_bib24","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/ncomms4571","article-title":"An alternate binding site for PPAR\u03b3 ligands","volume":"5","author":"Hughes","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116325_bib25","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1038\/s41401-022-00858-x","article-title":"Activation of the endocannabinoid system mediates cardiac hypertrophy induced by rosiglitazone","volume":"43","author":"Liu","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2024.116325_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s13300-017-0273-4","article-title":"Pioglitazone and the risk of bladder cancer: a meta-analysis","volume":"8","author":"Filipova","year":"2017","journal-title":"Diabetes. Ther."},{"key":"10.1016\/j.ejmech.2024.116325_bib27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bioorg.2018.02.009","article-title":"Thiazolidinediones as antidiabetic agents: a critical review","volume":"77","author":"Nanjan","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116325_bib28","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.bmcl.2019.06.027","article-title":"Discovery of BR102375, a new class of non-TZD PPAR\u03b3 full agonist for the treatment of type 2 diabetes","volume":"29","author":"Choung","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116325_bib29","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1021\/acs.jmedchem.9b01786","article-title":"Selective modulator of peroxisome proliferator-activated receptor \u03b3 with an unprecedented binding mode","volume":"63","author":"Hanke","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116325_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126664","article-title":"Design, synthesis, and evaluation of potent novel peroxisome proliferator-activated receptor \u03b3 indole partial agonists","volume":"29","author":"Eeda","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116325_bib31","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbrc.2015.07.011","article-title":"PPAR\u03b3 partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes","volume":"464","author":"Milton","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116325_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154434","article-title":"Magnolol effectively ameliorates diabetic peripheral neuropathy in mice","volume":"107","author":"Yang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2024.116325_bib33","doi-asserted-by":"crossref","first-page":"13124","DOI":"10.1021\/acs.jmedchem.0c01555","article-title":"A novel N-substituted valine derivative with unique peroxisome proliferator-activated receptor \u03b3 binding properties and biological activities","volume":"63","author":"Peiretti","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116325_bib34","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jmb.2009.01.025","article-title":"INT131: a selective modulator of PPAR gamma","volume":"386","author":"Motani","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.116325_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature09291","article-title":"Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5","volume":"466","author":"Choi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116325_bib36","first-page":"166","article-title":"Synthesis of urea acetates as potential PPAR\u03b1\/\u03b3 dual agonists, Chinese","volume":"19","author":"Zhao","year":"2008","journal-title":"Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116325_bib37","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.cgh.2023.01.018","article-title":"Saroglitazar, a Dual PPAR \u03b1\/\u03b3 Agonist, improves atherogenic dyslipidemia in patients with non-Cirrhotic nonalcoholic fatty liver disease: a pooled analysis","volume":"21","author":"Siddiqui","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116325_bib38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature10383","article-title":"Antidiabetic actions of a non-agonist PPAR\u03b3 ligand blocking Cdk5-mediated phosphorylation","volume":"477","author":"Choi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116325_bib39","first-page":"665","article-title":"Obesity-linked PPAR\u03b3 S273 phosphorylation promotes insulin resistance through growth differentiation factor 3, Cell","volume":"32","author":"Hall","year":"2020","journal-title":"Meta"},{"key":"10.1016\/j.ejmech.2024.116325_bib40","doi-asserted-by":"crossref","first-page":"26618","DOI":"10.1074\/jbc.M114.566794","article-title":"A novel non-agonist peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) ligand UHC1 blocks PPAR\u03b3 phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity","volume":"289","author":"Choi","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116325_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101030","article-title":"The therapeutic potential of inhibiting PPAR\u03b3 phosphorylation to treat type 2 diabetes","volume":"297","author":"Frkic","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116325_bib42","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1039\/C9SC05487A","article-title":"Identification and structural insight of an effective PPAR\u03b3 modulator with improved therapeutic index for anti-diabetic drug discovery","volume":"11","author":"Jiang","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2024.116325_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113653","article-title":"Identification of a novel PPAR\u03b3 modulator with good anti-diabetic therapeutic index via structure-based screening, optimization and biological validation","volume":"154","author":"Chen","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116325_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105860","article-title":"Identification of the anti-fungal drug fenticonazole nitrate as a novel PPAR\u03b3-modulating ligand with good therapeutic index: structure-based screening and biological validation","volume":"173","author":"Ma","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116325_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106191","article-title":"Structure-based screening and biological validation of the anti-thrombotic drug-dicoumarol as a novel and potent PPAR\u03b3-modulating ligand","volume":"129","author":"Ma","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116325_bib46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature13887","article-title":"An ERK\/CDK5 axis controls the diabetogenic actions of PPAR\u03b3","volume":"517","author":"Banks","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116325_bib47","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/acsmedchemlett.1c00715","article-title":"Discovery by virtual screening of an Inhibitor of CDK5-mediated PPAR\u03b3 phosphorylation","volume":"13","author":"O'Mahony","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116325_bib48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/07391102.2020.1714482","article-title":"Virtual screening, molecular dynamics, density functional theory and quantitative structure activity relationship studies to design peroxisome proliferator-activated receptor-\u03b3 agonists as anti-diabetic drugs","volume":"39","author":"Ahmed","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2024.116325_bib49","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2337\/db15-1382","article-title":"PPAR\u03b3 antagonist Gleevec improves insulin sensitivity and promotes the browning of white adipose tissue","volume":"65","author":"Choi","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2024.116325_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111682","article-title":"The effects of raloxifene on endothelial function and inflammation in postmenopausal women: a Meta-analysis of randomized controlled trials","volume":"159","author":"Kang","year":"2022","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ejmech.2024.116325_bib51","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1039\/C6SC01279E","article-title":"Mechanistic elucidation guided by covalent inhibitors for the development of anti-diabetic PPAR\u03b3 ligands","volume":"7","author":"Bae","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2024.116325_bib52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejmech.2014.11.044","article-title":"Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor \u03b1\/\u03b3 ligand LT175","volume":"90","author":"Piemontese","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116325_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4313561","article-title":"Chiglitazar preferentially regulates gene expression via configuration-restricted binding and phosphorylation inhibition of PPAR\u03b3","volume":"2017","author":"Pan","year":"2017","journal-title":"PPAR Res."},{"key":"10.1016\/j.ejmech.2024.116325_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101363","article-title":"A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice","volume":"54","author":"Wu","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejmech.2024.116325_bib55","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1111\/dom.13843","article-title":"A novel specific peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese mice","volume":"21","author":"Huan","year":"2019","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejmech.2024.116325_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","article-title":"Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR\u03b3): a review","volume":"92","author":"Wang","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116325_bib57","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.1116971109","article-title":"Amorfrutins are potent antidiabetic dietary natural products","volume":"109","author":"Weidner","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.116325_bib58","article-title":"Selective targeting of PPAR\u03b3 by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency","volume":"5","author":"Zheng","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116325_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9136282","article-title":"Crocin improves insulin sensitivity and ameliorates adiposity by regulating AMPK-CDK5-PPAR\u03b3 signaling","volume":"2020","author":"Fang","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2024.116325_bib60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/biom10020275","article-title":"Cyclin-dependent kinase 5 inhibitor butyrolactone I elicits a partial agonist activity of peroxisome proliferator-activated receptor \u03b3","volume":"10","author":"Ahn","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2024.116325_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.06.025","article-title":"Phloretin and phloridzin improve insulin sensitivity and enhance glucose uptake by subverting PPAR\u03b3\/Cdk5 interaction in differentiated adipocytes","volume":"383","author":"Kumar","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2024.116325_bib62","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1021\/jm501155f","article-title":"Peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) and ligand choreography: newcomers take the stage","volume":"58","author":"Garcia-Vallve","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116325_bib63","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbapap.2017.03.008","article-title":"Structural basis for differential activities of enantiomeric PPAR\u03b3 agonists: binding of S35 to the alternate site","volume":"1865","author":"Jang","year":"2017","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ejmech.2024.116325_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103059","article-title":"Selective PPAR\u03b3 modulator diosmin improves insulin sensitivity and promotes browning of white fat","volume":"299","author":"Yu","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116325_bib65","article-title":"AM-879, a PPARy non-agonist and Ser273 phosphorylation blocker, promotes insulin sensitivity without adverse effects in mice","volume":"17","author":"Terra","year":"2022","journal-title":"Metabol. Open."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T21:32:08Z","timestamp":1712266328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424002058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":65,"alternative-id":["S0223523424002058"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116325","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raloxifene-driven benzothiophene derivatives: Discovery, structural refinement, and biological evaluation as potent PPAR\u03b3 modulators based on drug repurposing","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116325"}}